Related Experiment Video
Updated: Aug 25, 2025
Author Spotlight: Establishing a Reliable Distal MCA Occlusion Model in Mice for Stroke Research
Published on: December 15, 2023
MMP-12 knockdown prevents secondary brain damage after ischemic stroke in mice
Vijay Arruri1, Anil K Chokkalla1, Soomin Jeong2
1Department of Neurological Surgery, University of Wisconsin-Madison, Madison, WI, USA.
Abstract:
We previously reported that increased expression of matrix metalloproteinase-12 (MMP-12) mediates blood-brain barrier disruption via tight junction protein degradation after focal cerebral ischemia in rats. Currently, we evaluated whether MMP-12 knockdown protects the post-stroke mouse brain and promotes better functional recovery. Adult male mice were injected with negative siRNA or MMP-12 siRNA (intravenous) at 5 min of reperfusion following 1 h transient middle cerebral artery occlusion. MMP-12 knockdown significantly reduced the post-ischemic infarct volume and improved motor and cognitive functional recovery. Mechanistically, MMP-12 knockdown ameliorated degradation of tight junction proteins zonula occludens-1, claudin-5, and occludin after focal ischemia. MMP-12 knockdown also decreased the expression of inflammatory mediators, including monocyte chemoattractant protein-1, tumor necrosis factor-α, and interleukin-6, and the expression of apoptosis marker cleaved caspase-3 after ischemia. Overall, the present study indicates that MMP-12 promotes secondary brain damage after stroke and hence is a promising stroke therapeutic target.
Insights
Matrix metalloproteinase-12 (MMP-12) inhibition protects the brain after stroke by reducing damage and improving recovery. This study highlights MMP-12 as a potential therapeutic target for stroke treatment.
Area of Science:
- Neuroscience
- Biochemistry
- Pharmacology
Background:
- Increased matrix metalloproteinase-12 (MMP-12) expression contributes to blood-brain barrier disruption after focal cerebral ischemia.
- MMP-12 degrades tight junction proteins, compromising brain tissue integrity post-stroke.
Purpose of the Study:
- To investigate the neuroprotective effects of MMP-12 knockdown in a mouse model of ischemic stroke.
- To determine if reducing MMP-12 expression improves functional recovery and reduces secondary brain damage.
Main Methods:
- Adult male mice underwent transient middle cerebral artery occlusion (1 hour) followed by reperfusion.
- MMP-12 specific small interfering RNA (siRNA) was administered intravenously at 5 minutes of reperfusion.
- Infarct volume, motor and cognitive functions, tight junction protein expression, inflammatory mediators, and apoptosis markers were assessed.
Main Results:
- MMP-12 knockdown significantly reduced post-ischemic infarct volume.
- Functional recovery, including motor and cognitive abilities, was markedly improved in MMP-12 siRNA-treated mice.
- MMP-12 knockdown preserved tight junction proteins (zonula occludens-1, claudin-5, occludin) and decreased inflammatory mediators (MCP-1, TNF-α, IL-6) and cleaved caspase-3 expression.
Conclusions:
- MMP-12 plays a critical role in promoting secondary brain damage following ischemic stroke.
- Targeting MMP-12 through knockdown strategies offers a promising therapeutic approach for stroke management.
- Reducing MMP-12 expression ameliorates blood-brain barrier disruption, inflammation, and apoptosis, leading to better neurological outcomes.
More Related Videos
09:48Quantification of Neurovascular Protection Following Repetitive Hypoxic Preconditioning and Transient Middle Cerebral Artery Occlusion in Mice
Published on: May 4, 2015
08:36A Versatile Murine Model of Subcortical White Matter Stroke for the Study of Axonal Degeneration and White Matter Neurobiology
Published on: March 17, 2016